Is Aveanna Healthcare Holdings Inc. a good investment? Aveanna Healthcare Holdings Inc. (AVAH) is currently trading at 9.61 USD. Market analysts have a consensus price target of 10.45 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 7.76. This relatively low multiple may signal that Aveanna Healthcare Holdings Inc. is undervalued compared to historical market norms.
Earnings Schedule: Aveanna Healthcare Holdings Inc. is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is 0.78.
No, it does not currently pay a dividend.
Aveanna Healthcare Holdings Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of 1.21.
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Community Discussion